1. All of FT
  2. Articles
  3. Blogs
  4. Multimedia
Showing 7 results
  1. April 23, 2008

    Medical devices shine

    ...base. With $32bn in global sales in 2007, the segment is expected to expand 10 per cent annually until 2011, according to Espicom, a consultancy. They expect the fastest growth in spinal products and the still-small area of tissue repair agents. Joint...

  2. April 22, 2008

    Medical devices shine

    ...base. With $32bn in global sales in 2007, the segment is expected to expand 10 per cent annually until 2011, according to Espicom, a consultancy. They expect the fastest growth in spinal products and the still-small area of tissue repair agents. Joint...

  3. November 22, 2007

    Novo Nordisk's pipeline

    ...treatments is growing rapidly, with annual sales expected to leap from more than $22bn this year to $31bn by 2011, according to Espicom Business Intelligence. As the world's largest insulin supplier, Novo benefits from economies of scale. It also makes hard...

  1. November 21, 2007

    Novo Nordisk’s pipeline

    ...treatments is growing rapidly, with annual sales expected to leap from more than $22bn this year to $31bn by 2011, according to Espicom Business Intelligence. As the world’s largest insulin supplier, Novo benefits from economies of scale. It also makes...

  2. July 27, 2005

    Swiss science rise above the crowd

    ...domestic markets. The Swiss spend a lot on drugs – $667 per head annually compared with the Germans’ $442 according to Espicom Business Intelligence – but there are not many of them. Switzerland is no bigger than Portugal as a drugs market. Novartis... John Gapper

  3. July 21, 2005

    Swiss science rises above the crowds

    ...markets. The Swiss spend a lot on drugs - $667 (£384) per head annually compared with the Germans' $442 according to Espicom Business Intelligence - but there are not many of them. Switzerland is no bigger than Portugal as a drugs market. Novartis...

  4. July 20, 2005

    John Gapper: Swiss science rises above crowds

    ...markets. The Swiss spend a lot on drugs – $667 (€556) per head annually compared with the Germans’ $442 according to Espicom Business Intelligence – but there are not many of them. Switzerland is no bigger than Portugal as a drugs market. Novartis... By John Gapper